Clinical Trials Browser

Not yet recruiting × OTHER × Carcinoma, Non-Small-Cell Lung × Clear all

NCT07163507 2026-03-18

RICEPS-2

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07479407 2026-03-18

PREHAB

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Postoperative Complications

NCT07477808 2026-03-17

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07001995 2026-03-16

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07472478 2026-03-16

GIVEN

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07322341 2026-03-13

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07469488 2026-03-13

AmiCARE

Phase 4 Not yet recruiting

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT07140315 2026-03-12

DK222 Study at Hopkins

Phase 1 Not yet recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07327736 2026-03-12

Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07463677 2026-03-11

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07461727 2026-03-10

An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07442292 2026-03-05

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Not yet recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma

NCT06634056 2026-03-04

P4-PACIFIC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06813664 2026-03-04

CURB-TKI

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07450183 2026-03-04

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07432802 2026-02-27

STRADOS

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07436598 2026-02-27

3D Virtual Resection for Predicting Lung Function in VATS

Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07440290 2026-02-27

DETERMINE

Phase 2/3 Not yet recruiting

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07432984 2026-02-25

FMT-LUNG

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06552000 2026-02-23

Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07382726 2026-02-20

Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06943664 2026-02-18

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07418866 2026-02-18

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07418879 2026-02-18

A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07412041 2026-02-17

PERCC

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07412262 2026-02-17

A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer With Acquired Resistance to Immunotherapy and High YAP Protein Expression

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07401056 2026-02-12

READY-LUNG

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Motor Activity, Pain

NCT07405086 2026-02-12

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Phase 2 Not yet recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07405190 2026-02-12

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07360743 2026-02-10

META-1

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07398209 2026-02-09

GCC 2546- Motion Management

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07383454 2026-02-03

Lung Cancer Screening in Population Who Had Never Smoked

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07377916 2026-01-30

NSCLC

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07372378 2026-01-28

Association of Different Tidal Volumes and Postoperative Pulmonary Complications

Not yet recruiting

Hypoxia, Carcinoma, Non-Small-Cell Lung

NCT07373899 2026-01-28

Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study.

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07365410 2026-01-26

Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study

Phase 2 Not yet recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT07020065 2026-01-21

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07298148 2026-01-21

Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mg

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07354061 2026-01-21

TD-ENSEMBLE

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07355205 2026-01-21

FLINN

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07351565 2026-01-20

CPPGPTCLC

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07353476 2026-01-20

Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07348965 2026-01-16

Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT07343479 2026-01-15

Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases

Phase 2 Not yet recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT07339839 2026-01-14

Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07337096 2026-01-13

Electro-Acupuncture in Lung cancER : EALER Study

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07333651 2026-01-12

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Phase 2 Not yet recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07323641 2026-01-07

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07310589 2026-01-06

Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung Cancer

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07314216 2026-01-06

Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung